Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Compounds from the plant Mammea siamensis may help treat hair loss.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

The Spanish HSS-29 scale effectively measures changes in life quality due to female-pattern hair loss.

Finasteride for hair loss in young men increases the risk of sexual dysfunction.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

High TNF-α levels may increase hair loss risk after PRP therapy.

Post-finasteride syndrome can cause sexual and systemic side effects, and patients should be informed about these risks.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Nucleic acid polymers can enhance antiviral responses and improve treatment outcomes for chronic hepatitis B.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Finasteride and dutasteride have little effect on Type 2 Diabetes risk.

Purple corn extract may help reduce prostate enlargement and inflammation.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

Oral minoxidil is as effective and safe as topical minoxidil for treating female pattern hair loss.

Patients with a specific genetic variant have more severe alopecia areata and higher recurrence rates.

Methylated gene parts may cause finasteride-resistance in some enlarged prostate patients.

Rice bran extract might help prevent hair loss.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

A mix of Platycladus orientalis leaf extract and alpha-terpineol helps mice grow hair by increasing growth factors and cell growth.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.